- Filed
- Feb 22, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Feb 20, 2024 | 136.93M sh |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $283.95M |
| Cash And Equivalents | FY 2023 · Dec 31, 2021 | $270.09M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $1.4B |
| Total Assets | FY 2023 · Dec 31, 2022 | $2.07B |
| Shares Diluted | FY 2023 · Dec 31, 2021 | 163.37M sh |
| Stock Repurchased | FY 2023 · Dec 31, 2021 | $0 |
| Capex | FY 2023 · Dec 31, 2021 | $17.33M |
| Operating Cash Flow | FY 2023 · Dec 31, 2021 | $29.64M |
| Eps Diluted | FY 2023 · Dec 31, 2021 | −$0.55 |
| Eps Basic | FY 2023 · Dec 31, 2021 | −$0.55 |
| Sga Expense | FY 2023 · Dec 31, 2021 | $119.9M |
| Net Income | FY 2023 · Dec 31, 2021 | −$89.68M |
| Operating Income | FY 2023 · Dec 31, 2021 | −$24.24M |
| Revenue | FY 2023 · Dec 31, 2021 | $534.64M |
| Stockholders Equity restated | FY 2023 · Dec 31, 2020 | $560.82M |